Evaluating the Causal Effects of Circulating Proteome on the Risk of Sepsis and Related Outcomes
- PMID: 38854583
- PMCID: PMC11154893
- DOI: 10.1021/acsomega.4c01934
Evaluating the Causal Effects of Circulating Proteome on the Risk of Sepsis and Related Outcomes
Abstract
The current investigation deployed Mendelian randomization (MR) to elucidate the causal relationship between circulating proteins and sepsis. A rigorous two-sample MR analysis evaluated the effect of plasma proteins on the sepsis susceptibility. To affirm the integrity of MR findings, a suite of supplementary analyses, including Bayesian colocalization, Steiger filtering, the assessment of protein-altering polymorphisms, and the correlation between expression quantitative trait loci and protein quantitative trait loci (pQTLs), was employed. The study further integrated the examination of protein-protein interactions and pathway enrichment, along with the identification of pharmacologically actionable targets, to advance our comprehension and outline potential sepsis therapies. Subsequent analyses leveraging cis-pQTLs within MR studies unveiled noteworthy relationships: 94 specific proteins exhibited significant links with sepsis-related 28 day mortality, while 96 distinct proteins correlated with survival outcomes in sepsis. Furthermore, incorporating both cis- and trans-pQTLs in MR investigations revealed more comprehensive findings, associating 201 unique proteins with sepsis-related 28 day mortality and 199 distinct proteins with survival outcomes in sepsis. Markedly, colocalization analyses confirmed that eight of these proteins exhibited prominent evidence for colocalization, emphasizing their potential criticality in sepsis pathophysiology. Further in silico analyses were conducted to delineate putative regulatory networks and to highlight prospective drug targets among these proteins. Employing the MR methodology has shed light on plasma proteins implicated in the etiopathogenesis of sepsis. This novel approach unveiled numerous biomarkers and targets, providing a scientific rationale for the development of new therapeutic strategies and prophylactic measures against sepsis.
© 2024 The Authors. Published by American Chemical Society.
Conflict of interest statement
The authors declare no competing financial interest.
Figures


Similar articles
-
Association Analysis of the Circulating Proteome With Sarcopenia-Related Traits Reveals Potential Drug Targets for Sarcopenia.J Cachexia Sarcopenia Muscle. 2025 Feb;16(1):e13720. doi: 10.1002/jcsm.13720. J Cachexia Sarcopenia Muscle. 2025. PMID: 39949133 Free PMC article.
-
Evaluating the Causal Effect of Circulating Proteome on Glycemic Traits: Evidence From Mendelian Randomization.Diabetes. 2025 Jan 1;74(1):108-119. doi: 10.2337/db24-0262. Diabetes. 2025. PMID: 39418314
-
PTGES2 and RNASET2 identified as novel potential biomarkers and therapeutic targets for basal cell carcinoma: insights from proteome-wide mendelian randomization, colocalization, and MR-PheWAS analyses.Front Pharmacol. 2024 Jul 5;15:1418560. doi: 10.3389/fphar.2024.1418560. eCollection 2024. Front Pharmacol. 2024. PMID: 39035989 Free PMC article.
-
The Causal Relationships and Therapeutic Targets of Plasma Proteins in Ankylosing Spondylitis.Biomedicines. 2025 Jan 27;13(2):306. doi: 10.3390/biomedicines13020306. Biomedicines. 2025. PMID: 40002719 Free PMC article.
-
Integrating plasma protein-centric multi-omics to identify potential therapeutic targets for pancreatic cancer.J Transl Med. 2024 Jun 10;22(1):557. doi: 10.1186/s12967-024-05363-9. J Transl Med. 2024. PMID: 38858729 Free PMC article.
Cited by
-
Identifying potential drug targets for sepsis-related adult respiratory distress syndrome through comprehensive genetic analysis and druggability assessment.J Glob Health. 2025 Mar 21;15:04117. doi: 10.7189/jogh.15.04117. J Glob Health. 2025. PMID: 40116326 Free PMC article.
References
-
- Singer M.; Deutschman C. S.; Seymour C. W.; Shankar-Hari M.; Annane D.; Bauer M.; Bellomo R.; Bernard G. R.; Chiche J. D.; Coopersmith C. M.; et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA 2016, 315 (8), 801–810. 10.1001/jama.2016.0287. - DOI - PMC - PubMed
-
- Rudd K. E.; Johnson S. C.; Agesa K. M.; Shackelford K. A.; Tsoi D.; Kievlan D. R.; Colombara D. V.; Ikuta K. S.; Kissoon N.; Finfer S.; et al. Global, regional, and national sepsis incidence and mortality, 1990–2017: analysis for the Global Burden of Disease Study. Lancet 2020, 395 (10219), 200–211. 10.1016/S0140-6736(19)32989-7. - DOI - PMC - PubMed
-
- Emilsson V.; Gudmundsdottir V.; Gudjonsson A.; Jonmundsson T.; Jonsson B. G.; Karim M. A.; Ilkov M.; Staley J. R.; Gudmundsson E. F.; Launer L. J.; et al. Coding and regulatory variants are associated with serum protein levels and disease. Nat. Commun. 2022, 13 (1), 481.10.1038/s41467-022-28081-6. - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources